| Zacks Company Profile for Lantheus Holdings, Inc. (LNTH : NSDQ) |
|
|
| |
| • Company Description |
| Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States.
Number of Employees: 1,193 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $74.91 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 873,491 shares |
| Shares Outstanding: 64.61 (millions) |
| Market Capitalization: $4,839.63 (millions) |
| Beta: -0.11 |
| 52 Week High: $111.29 |
| 52 Week Low: $47.25 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
11.94% |
12.92% |
| 12 Week |
18.34% |
18.19% |
| Year To Date |
12.56% |
12.02% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
201 BURLINGTON ROAD SOUTH BUILDING
-
BEDFORD,MA 01730
USA |
ph: 978-671-8001
fax: 978-671-8860 |
ir@lantheus.com |
http://www.lantheus.com |
|
|
| |
| • General Corporate Information |
Officers
Mary Anne Heino - Chief Executive Officer and Chairperson
Robert J. Marshall - Chief Financial Officer and Treasurer
Kimberly Brown - Chief Accounting Officer
Minnie Baylor-Henry - Director
Gerard Ber - Director
|
|
Peer Information
Lantheus Holdings, Inc. (BJCT)
Lantheus Holdings, Inc. (CADMQ)
Lantheus Holdings, Inc. (APNO)
Lantheus Holdings, Inc. (UPDC)
Lantheus Holdings, Inc. (IMTIQ)
Lantheus Holdings, Inc. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 516544103
SIC: 2835
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/25
Next Expected EPS Date: 05/06/26
|
|
Share - Related Items
Shares Outstanding: 64.61
Most Recent Split Date: (:1)
Beta: -0.11
Market Capitalization: $4,839.63 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $1.05 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $4.63 |
Payout Ratio: 0.00 |
| Number of Estimates in the Fiscal Year Consensus: 8.00 |
Change In Payout Ratio: 0.00 |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 05/06/26 |
|
|
|
| |
